Cell Therapy Primer
Cell Therapy Primer offers a comprehensive introduction to cell therapy development, manufacturing, and commercialization. This class delves into the scientific benefits and challenges of autologous and allogeneic cell therapies. Cell Therapy Primer focuses especially on Chimeric Antigen Receptors (CARs), Â their proven approach to treating blood cancer, and their potential applications in solid tumors and beyond. The course also introduces stem cell therapies and applications in regenerative medicine. Enroll now to gain an understanding of the groundbreaking potential of cell therapy!
Section 1: Introduction to Cell Therapy
Provides an overview of the first cell therapies and compares two types of cells commercially available today for cell therapy development.
Section 2: Chimeric Antigen Receptor (CAR)
Learn the immune system’s role and how cancer evades it. We end the section by explaining how Chimeric Antigen Receptors (CARs) are used in cell therapy to detect and destroy malignant cells.
Section 3: Commercial Landscape of CAR-T Cells
CAR-T was first developed by Israeli immunologists Zelig Eshhar and Gideon Gross between 1989-1993. In section three, we discuss the commercial landscape of CAR-T.
Section 4: Next-Generation Therapies
Explore the next-generation derivatives of CAR-T cells and investigate exciting new cell line frontiers.
How to Attach Your Course Certificate to LinkedIn
LinkedIn Certificate Demo
Five Takeaways
- Identify stem cell therapies and list their applications in regenerative medicine.
- Explain the general mechanism of action for Chimeric Antigen Receptors (CARs).
- Evaluate the commercial viability of CAR-T cell therapy to predict its real-world impact to transform medicine.
- Explore ongoing innovations and potential use of CARs with cell types other than T-cells for solid tumors.
- Paraphrase the steps used in manufacturing CAR-T for use in patients.
Features
- Closed Captioning in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Transcripts in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Course materials
- Real-time tracking
- Progress reporting
- Accessibility features
- Corporate account upgrades
- LinkedIn certificate attachment
- Verified certificates
FAQ
- How long do I have to complete an on-demand course? You have one year from the date of purchase to complete the course. During that year, you may watch the class an unlimited number of times.
- What happens if I don’t complete the course in one year? There are no time extensions. If you want to complete the course, you must purchase it again.
- How long are the on-demand classes? Our longest course has a running time of 90 minutes. However, most have a running time of 45 minutes. The running time is listed for each class on its registration page. The assessment at the end of each course takes between 10-20 minutes to complete.
- Are there any downloadable class materials? No. All course slides and transcripts remain on your Biotech Primer dashboard, but they are always available for review.
- What is the format of the on-demand classes? The online class begins with the class objectives and the course itself and ends with a summary of what you learned. The course is a series of images and text accompanied by a professional voice-over and subtitles. Subtitles are available in 9 languages. The course ends with a quiz to assess your understanding.
- Can I repeat the course? You can repeat the course as often as you like within your one-year access.
- How many times can I take the course quiz? You have three chances to pass the quiz. A passing score is 75% or higher. You must pass the quiz to receive the class certificate. Your quiz score will be shown on your class certificate.
- May I share a course I purchased with others? Each course is to be taken by one individual. If you want to learn as a group, please contact us at training@biotechprimer.com for group pricing.
Ready to get started?
Get in touch or enroll now